Compare AURA & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | QD |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 807.5M |
| IPO Year | 2021 | 2017 |
| Metric | AURA | QD |
|---|---|---|
| Price | $6.52 | $4.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.20 | N/A |
| AVG Volume (30 Days) | 190.9K | ★ 310.9K |
| Earning Date | 11-13-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2364.38 |
| EPS | N/A | ★ 0.67 |
| Revenue | N/A | ★ $12,647,260.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.95 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $2.04 |
| 52 Week High | $9.04 | $5.08 |
| Indicator | AURA | QD |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 36.04 |
| Support Level | $6.27 | $3.89 |
| Resistance Level | $6.55 | $4.91 |
| Average True Range (ATR) | 0.30 | 0.20 |
| MACD | 0.06 | -0.10 |
| Stochastic Oscillator | 89.80 | 18.63 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.